Results 141 to 150 of about 1,234,720 (380)

Aluminum abundances of multiple stellar generations in the globular cluster NGC 1851

open access: yes, 2012
We study the distribution of aluminum abundances among red giants in the peculiar globular cluster NGC 1851. Aluminum abundances were derived from the strong doublet Al I 8772-8773 A measured on intermediate resolution FLAMES spectra of 50 cluster stars ...
Arnould   +35 more
core   +1 more source

The abundance of brown dwarfs [PDF]

open access: yesMonthly Notices of the Royal Astronomical Society, 1999
The amount of mass contained in low-mass objects is investigated anew. Instead of using a mass-luminosity relation to convert a luminosity function to a mass function, I predict the mass-luminosity relation from assumed mass functions and the luminosity functions of Jahreiss & Wielen (1997) and Gould et al (1997).
openaire   +6 more sources

Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities

open access: yesMolecular Oncology, EarlyView.
Urine is a rich source of biomarkers for cancer detection. Tumor‐derived material is released into the bloodstream and transported to the urine. Urine can easily be collected from individuals, allowing non‐invasive cancer detection. This review discusses the rationale behind urine‐based cancer detection and its potential for cancer diagnostics ...
Birgit M. M. Wever   +1 more
wiley   +1 more source

The Oxygen Abundance of Nearby Galaxies from Sloan Digital Sky Survey Spectra

open access: yes, 2007
We have derived the oxygen abundance for a sample of nearby galaxies in the Data Release 5 of the Sloan Digital Sky Survey (SDSS) which possess at least two independent spectra of one or several HII regions with a detected [OIII]4363 auroral line. Since,
Campbell A.   +10 more
core   +1 more source

Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies

open access: yesMolecular Oncology, EarlyView.
Pre‐analytical variables strongly influence the analysis of extracellular RNA (cell‐free RNA; exRNA) derived from blood plasma. Their reporting is essential to allow interpretation and replication of results. By evaluating 200 exRNA studies, we pinpoint a lack of reporting pre‐analytical variables associated with blood collection, plasma preparation ...
Céleste Van Der Schueren   +16 more
wiley   +1 more source

Advances in Stellar and Galactic Evolution with the Population of Planetary Nebula Progenitors from the APOGEE DR17 Survey

open access: yesGalaxies
Planetary nebulae (PNe) are the ejected gas and dust shells of evolved low- and intermediate-mass stars (LIMSs). We present an abundance comparison between PNe and their progenitors to reveal their similarities and differences since such a comparison has
Letizia Stanghellini   +3 more
doaj   +1 more source

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink   +6 more
wiley   +1 more source

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

open access: yesMolecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi   +3 more
wiley   +1 more source

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy